Insiders · Profile

BLICKENSTAFF KIM D

Director at TANDEM DIABETES CARE · Director at Nuvation Bio. Filing since 23 Mar 2017. CIK 0001238913

Company
Date
Role
Action
Shares
Amount
Of holding
21 Nov 2024
Director
Sold at will
30,000
$941.40K
15.4%
20 Nov 2024
Director
Sold at will
10,000
$300.00K
4.9%
11 Jun 2024
Director
Bought
172,189
$500.09K
opened
17 May 2022
Director
Sold, plan not stated
10,762
$999.90K
5.0%
2 Sep 2021
Director
Sold, plan not stated
28,700
$3.25M
12.4%
17 Aug 2021
Director
Sold, plan not stated
25,760
$2.80M
11.3%
16 Aug 2021
Director
Sold, plan not stated
24,240
$2.64M
9.6%
13 Aug 2021
Director
Sold, plan not stated
50,000
$5.36M
16.5%
12 Aug 2021
Director
Sold, plan not stated
13,990
$1.48M
4.4%
10 Aug 2021
Director
Sold, plan not stated
3,210
$344.13K
1.0%
9 Aug 2021
Director
Sold, plan not stated
80,000
$8.61M
20.0%
6 Aug 2021
Director
Sold, plan not stated
2,800
$306.30K
0.7%
8 Jun 2021
Director
Sold, plan not stated
38,000
$3.35M
8.4%
16 Mar 2021
Director
Sold, plan not stated
51,022
$4.47M
10.1%
15 Mar 2021
Director
Sold, plan not stated
148,978
$12.99M
22.8%
16 Dec 2020
Director
Sold, plan not stated
94,600
$8.26M
12.7%
15 Dec 2020
Director
Sold, plan not stated
13,598
$1.26M
1.8%
11 Dec 2020
Director
Sold, plan not stated
9,150
$850.95K
1.2%
9 Dec 2020
Director
Sold, plan not stated
15,850
$1.50M
2.0%
1 Dec 2020
Director
Sold, plan not stated
25,000
$2.43M
2.9%
12 Nov 2020
Director
Sold, plan not stated
16,802
$1.80M
1.9%
10 Nov 2020
Director
Sold, plan not stated
25,000
$2.50M
2.8%
18 Aug 2020
Director
Sold, plan not stated
38,250
$3.96M
4.1%
10 Aug 2020
Director
Sold, plan not stated
8,882
$922.67K
1.0%
7 Aug 2020
Director
Sold, plan not stated
161,244
$17.13M
17.1%
6 Aug 2020
Director
Sold, plan not stated
122,298
$12.92M
19.7%
30 Jun 2020
Director
Sold, plan not stated
50,000
$4.78M
7.9%
29 Jan 2020
Executive Chairman
Sold, plan not stated
50,000
$3.80M
7.2%
16 Dec 2019
Executive Chairman
Sold, plan not stated
200,000
$11.97M
22.4%
29 Aug 2019
Executive Chairman
Sold, plan not stated
80,000
$5.68M
8.2%
28 Aug 2019
Executive Chairman
Sold, plan not stated
20,000
$1.42M
2.0%
11 Mar 2019
Executive Chairman
Sold, plan not stated
200,000
$12.99M
16.8%
7 Nov 2018
PRESIDENT & CEO
Sold, plan not stated
178,730
$6.61M
13.0%
6 Nov 2018
PRESIDENT & CEO
Sold, plan not stated
19,270
$712.99K
1.4%
9 Feb 2018
PRESIDENT & CEO
Bought
750,000
$1.50M
154%
13 Oct 2017
PRESIDENT & CEO
Bought
285,700
$999.95K
142%
23 Mar 2017
PRESIDENT & CEO
Bought
1,600,000
$2.00M
392%
37 decisions on file.